RESUMO
The incidence of BCG ostitis was studied by the data of questionnaires sent from 36 areas of the Russian Federation (RF). Particular emphasis is laid on 15 northwestern RF regions where an indepth study dealing with the 2000-2004 detection rates of postvaccination osseous complications was conducted. The mean incidence rate was 6.62 per 100,000 vaccinated persons with great data differences between the regions. The reasons for the detected differences and the perspectives of further studies of the epidemiological indices of the incidence of postvaccination osseous complications are analyzed.
Assuntos
Adjuvantes Imunológicos/efeitos adversos , Vacina BCG/efeitos adversos , Osteíte/induzido quimicamente , Osteíte/epidemiologia , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Estudos Retrospectivos , Federação Russa/epidemiologia , Tuberculose/prevenção & controleRESUMO
Age- and nationality-specific analysis of the trends observed in tuberculosis epidemiology in the Extreme North of Russia objectively shows the role of growing reserve of tuberculous infection among native population in small towns for epidemiological situation in large cities with formation of common epidemiological space in these regions.
Assuntos
Tuberculose/epidemiologia , Adulto , Fatores Etários , Criança , Estudos Transversais , Humanos , Federação Russa/epidemiologia , População UrbanaRESUMO
Immunologic screening was used for examining children of five St. Petersburg regions (4155 subjects) and workers of two industrial enterprises (7700 subjects). Tuberculosis infection level in children living together with subjects of groups I, II, Va, Vb and VII dispensary record and tuberculin sensitivity in adults were determined. New risk groups of tuberculosis development have been suggested which include children from the families of subjects with residual changes of past respiratory tuberculosis with a high risk of its reactivation and adults having hyperergic tuberculin sensitivity. BCG revaccination postponement in adults aged 27-30 years is valid in conditions of low tuberculosis prevalence.
